Exact Mass: 500.1229

Nocardicin A

C23H24N4O9 (500.1543)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

(S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(acetylthio)methyl-1-oxoprolyl]-(S)-alanine benzyl ester

C25H28N2O7S (500.1617)

1843U89

C27H24N4O6 (500.1696)

Nocardicin B

C23H24N4O9 (500.1543)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

Orcein

C28H24N2O7 (500.1583)

Once used as a food colouring but now banned throughout the EC Cudbear is a dye extracted from orchil lichens that produces colours in the purple range. It can be used to dye wool and silk, without the use of mordant. Cudbear was the first dye to be invented in modern times, and one of the few dyes to be credited to a named individual. Orcinol is extracted from archil lichen, Rocella tinctoria. It is then converted to orcein by ammonia and air. Orcein is a reddish-brown dye, orchil is a purple-blue dye. Orcein is also used as a stain in microscopy to visualize elastic fibers,Hepatitis B surface antigens and copper associated proteins. It is a mixture of phenoxazone derivates - hydroxyorceins, aminoorceins, and aminoorceinimines.

Lyoniresinol 9'-sulfate

C22H28O11S (500.1352)

Lyoniresinol 9-sulfate is found in green vegetables. Lyoniresinol 9-sulfate is a constituent of the roots of Polygonum cuspidatum (Japanese knotweed).

S)-2-(5(((1,2-Dihydro-3-methyl-1-oxobenzo(F)quinazolin-9-YL)methyl)amino)1-oxo-2-isoindolinyl)glutaric acid

C27H24N4O6 (500.1696)

Baohuoside II

C26H28O10 (500.1682)

(E)-N-(2-(((3-(4-Chlorophenyl)allyl)(methyl)amino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide

C26H29ClN2O4S (500.1536)

Nocardicin A

C23H24N4O9 (500.1543)

Simotinib

C25H26ClFN4O4 (500.1627)

Ikarisoside A

C26H28O10 (500.1682)

Baohuoside II is a natural product found in Epimedium grandiflorum, Epimedium diphyllum, and other organisms with data available. IKarisoside A (Icarisoside-A) is a natural flavonol glycoside and has anti-inflammatory properties. IKarisoside A (Icarisoside-A) is a natural flavonol glycoside and has anti-inflammatory properties.

Curtisian P

C29H24O8 (500.1471)

sideroxylonal A

C26H28O10 (500.1682)

Gnetuhainin J

C29H24O8 (500.1471)

Genisteone

C26H28O10 (500.1682)

Puerarin 4,6-diacetate

C25H24O11 (500.1319)

Guibourtinidol-(4alpha-

C29H24O8 (500.1471)

Gliocladinin B

C26H28O10 (500.1682)

Malibatol B

C28H20O9 (500.1107)

Gericudranin D

C29H24O8 (500.1471)

Apigenin 7-(6-crotonylglucoside)

C25H24O11 (500.1319)

2,3-di-O-Acetylfrangulin A

C25H24O11 (500.1319)

Jasmolactone C

C26H28O10 (500.1682)

Epigallocatechin 5,3,5-trimethyl ether 3-O-gallate

C25H24O11 (500.1319)

MEGxp0_000848

C22H28O13 (500.153)

16198-01-9

C25H24O11 (500.1319)

1,4,5-trihydroxynaphthalene 1,4-di-O-beta-D-glucopyranoside|5-hydroxynaphthalene-1,4-di-O-beta-D-glucopyranoside|juglanoside F

C22H28O13 (500.153)

ST077077

C22H28O13 (500.153)

Penta-Ac-2,3,4,4,5-Pentahydroxyflavan

C25H24O11 (500.1319)

Trichochrome F

C22H20N4O6S2 (500.0824)

3-(2,4-di-O-acetyl-alpha-L-rhamnopyranosyl)emodin

C25H24O11 (500.1319)

Epimedoside B

C26H28O10 (500.1682)

(E)-2-(6-(bis(4-hydroxyphenyl)methylene)-5-(4-hydroxyphenyl)cyclohexa-2,4-dienylidene)-1-(4-hydroxyphenyl)ethanone|selaginellin G

C33H24O5 (500.1624)

3-(3,4-di-O-acetyl-alpha-L-rhamnopyranosyl)emodin

C25H24O11 (500.1319)

FT-0775735

C26H28O10 (500.1682)

C22H28O13

C22H28O13 (500.153)

Diospyrosid

C22H28O13 (500.153)

(betaS,2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3,5,7-trihydroxy-beta-(2,4,5-trihydroxyphenyl)-2H-1-benzopyran-6-propanoic acid methyl ester|6-[(1S)-3-methoxy-3-oxo-1-(2,4,5-trihydroxyphenyl)propyl]catechin

C25H24O11 (500.1319)

120722-04-5

C26H28O10 (500.1682)

5-Methylcoumarin-4-cellobioside

C22H28O13 (500.153)

Penta-Ac-Nubigenol

C25H24O11 (500.1319)

5-[(1E)-2-(4beta-D-glucopyranosyloxyphenyl)ethenyl]-4,7-dimethoxy-3-methyl-2H-1-benzopyran-2-one

C26H28O10 (500.1682)

gnetoflavanol E

C29H24O8 (500.1471)

5-Methylcoumarin-4-gentiobioside

C22H28O13 (500.153)

C26H28O10

C26H28O10 (500.1682)

Guibourtinidol-(4alpha->2)-3,5,3,4-tetrahydroxystilbene

C29H24O8 (500.1471)

gneafricanin A

C29H24O8 (500.1471)

grandinal

C26H28O10 (500.1682)

Curguligine B

C19H26Cl2O11 (500.0852)

(+)-gallocatechin-8-S-beta-D-glucopyranoside|excoecariphenol B

C21H24O12S (500.0988)

(6-trans-p-coumaroyl)-3-O-beta-D-glucopyranosyl-(5-acetyl)-2-deoxy-D-ribonic acid

C22H28O13 (500.153)

6-(beta-D-glucopyranosyl)oxy-7-hydroxy-3-[(2-oxo-2H-1-benzopyran-7-yl)oxy]-2H-1-benzopyran-2-one|daphneretusin A

C24H20O12 (500.0955)

gnaphaffine A

C25H24O11 (500.1319)

6,7-dihydroxy-3-methoxy-8-[2-oxo-2H-1-benzopyran-7-(O-beta-D-glucopyranosyl)-8-yl]-2H-1-benzopyran-2-one

C24H20O12 (500.0955)

Trichochrome E

C22H20N4O6S2 (500.0824)

3-O-p-coumaroyl-5-O-caffeoylquinic acid|3-p-(E)-coumaroyl-5-(E)-caffeoylquinic acid

C25H24O11 (500.1319)

1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinic acid

C25H24O11 (500.1319)

Tri-Ac-Menegazziaic acid

C24H20O12 (500.0955)

Chloroenhydrin

C23H29ClO10 (500.1449)

2,4,6-trihydroxybenzoic acid-4-O-2,3,4,6-tetraacetylglucoside

C21H24O14 (500.1166)

Lawsoniaside

C22H28O13 (500.153)

gnetoflavanol B

C29H24O8 (500.1471)

1,4,5-trihydroxynaphthalene 1,5-di-O-beta-D-glucopyranoside|juglanoside G

C22H28O13 (500.153)

Penta-Ac-(-)-3,4,4,5,7-Pentahydroxyflavan

C25H24O11 (500.1319)

7-O-[beta-D-glucopyranosyl]-6-hydroxy-3-(2-oxo-2H-1-benzopyran-7-yl)-2H-1-benzopyran-2-one

C24H20O12 (500.0955)

gneafricanin B

C29H24O8 (500.1471)

(2R,3R)-7,4-dihydroxy-5,3,5-trimethoxyflavan-3-O-gallate

C25H24O11 (500.1319)

5-Carboxypyranopelargonidin 3-O-beta-glucopyranoside

C24H20O12 (500.0955)

Drynachromoside A

C22H28O13 (500.153)

Haploperoside C

C22H28O13 (500.153)

relative retention time with respect to 9-anthracene Carboxylic Acid is 0.543 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.542

6-methoxy-7-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-2-one

C22H28O13 (500.153)

6-hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

C24H20O12 (500.0955)

C22H28O13_3-[6-({6-O-[(2R,3R,4R)-3,4-Dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranosyl}oxy)-1-benzofuran-5-yl]propanoic acid

C22H28O13 (500.153)

6-methoxy-7-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-2-one

C22H28O13 (500.153)

Catechin pentaacetate

C25H24O11 (500.1319)

Epicatechin Pentaacetate

C25H24O11 (500.1319)

6-hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one [IIN-based on: CCMSLIB00000846875]

C24H20O12 (500.0955)

6-hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one [IIN-based: Match]

C24H20O12 (500.0955)

Catechin Pentaacetate_major

C25H24O11 (500.1319)

Catechin Pentaacetate_0.7\\%

C25H24O11 (500.1319)

Cys Cys Glu Phe

C20H28N4O7S2 (500.1399)

Cys Cys Phe Glu

C20H28N4O7S2 (500.1399)

Cys Asp Thr Tyr

C20H28N4O9S (500.1577)

Cys Asp Tyr Thr

C20H28N4O9S (500.1577)

Cys Glu Cys Phe

C20H28N4O7S2 (500.1399)

Cys Glu Phe Cys

C20H28N4O7S2 (500.1399)

Cys Glu Ser Tyr

C20H28N4O9S (500.1577)

Cys Glu Tyr Ser

C20H28N4O9S (500.1577)

Cys Phe Cys Glu

C20H28N4O7S2 (500.1399)

Cys Phe Glu Cys

C20H28N4O7S2 (500.1399)

Cys Ser Glu Tyr

C20H28N4O9S (500.1577)

Cys Ser Tyr Glu

C20H28N4O9S (500.1577)

Cys Thr Asp Tyr

C20H28N4O9S (500.1577)

Cys Thr Tyr Asp

C20H28N4O9S (500.1577)

Cys Tyr Asp Thr

C20H28N4O9S (500.1577)

Cys Tyr Glu Ser

C20H28N4O9S (500.1577)

Cys Tyr Ser Glu

C20H28N4O9S (500.1577)

Cys Tyr Thr Asp

C20H28N4O9S (500.1577)

Asp Cys Thr Tyr

C20H28N4O9S (500.1577)

Asp Cys Tyr Thr

C20H28N4O9S (500.1577)

Asp Asp Asp His

C18H24N6O11 (500.1503)

Asp Asp His Asp

C18H24N6O11 (500.1503)

Asp His Asp Asp

C18H24N6O11 (500.1503)

Asp Thr Cys Tyr

C20H28N4O9S (500.1577)

Asp Thr Tyr Cys

C20H28N4O9S (500.1577)

Asp Tyr Cys Thr

C20H28N4O9S (500.1577)

Asp Tyr Thr Cys

C20H28N4O9S (500.1577)

Glu Cys Cys Phe

C20H28N4O7S2 (500.1399)

Glu Cys Phe Cys

C20H28N4O7S2 (500.1399)

Glu Cys Ser Tyr

C20H28N4O9S (500.1577)

Glu Cys Tyr Ser

C20H28N4O9S (500.1577)

Glu Phe Cys Cys

C20H28N4O7S2 (500.1399)

Glu Ser Cys Tyr

C20H28N4O9S (500.1577)

Glu Ser Tyr Cys

C20H28N4O9S (500.1577)

Glu Tyr Cys Ser

C20H28N4O9S (500.1577)

Glu Tyr Ser Cys

C20H28N4O9S (500.1577)

Phe Cys Cys Glu

C20H28N4O7S2 (500.1399)

Phe Cys Glu Cys

C20H28N4O7S2 (500.1399)

Phe Glu Cys Cys

C20H28N4O7S2 (500.1399)

His Asp Asp Asp

C18H24N6O11 (500.1503)

Ser Cys Glu Tyr

C20H28N4O9S (500.1577)

Ser Cys Tyr Glu

C20H28N4O9S (500.1577)

Ser Glu Cys Tyr

C20H28N4O9S (500.1577)

Ser Glu Tyr Cys

C20H28N4O9S (500.1577)

Ser Tyr Cys Glu

C20H28N4O9S (500.1577)

Ser Tyr Glu Cys

C20H28N4O9S (500.1577)

Thr Cys Asp Tyr

C20H28N4O9S (500.1577)

Thr Cys Tyr Asp

C20H28N4O9S (500.1577)

Thr Asp Cys Tyr

C20H28N4O9S (500.1577)

Thr Asp Tyr Cys

C20H28N4O9S (500.1577)

Thr Tyr Cys Asp

C20H28N4O9S (500.1577)

Thr Tyr Asp Cys

C20H28N4O9S (500.1577)

Tyr Cys Asp Thr

C20H28N4O9S (500.1577)

Tyr Cys Glu Ser

C20H28N4O9S (500.1577)

Tyr Cys Ser Glu

C20H28N4O9S (500.1577)

Tyr Cys Thr Asp

C20H28N4O9S (500.1577)

Tyr Asp Cys Thr

C20H28N4O9S (500.1577)

Tyr Asp Thr Cys

C20H28N4O9S (500.1577)

Tyr Glu Cys Ser

C20H28N4O9S (500.1577)

Tyr Glu Ser Cys

C20H28N4O9S (500.1577)

Tyr Ser Cys Glu

C20H28N4O9S (500.1577)

Tyr Ser Glu Cys

C20H28N4O9S (500.1577)

Tyr Thr Cys Asp

C20H28N4O9S (500.1577)

Tyr Thr Asp Cys

C20H28N4O9S (500.1577)

EUK 118

C22H25MnN2O8 (500.0991)

KN-93

C26H29ClN2O4S (500.1536)

D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

Nap-TyrMe-OH

C28H24N2O7 (500.1583)

Tyr-Nap-OH

C28H24N2O7 (500.1583)

Orcein

C28H24N2O7 (500.1583)

D004396 - Coloring Agents

Lyoniresinol 9'-sulfate

C22H28O11S (500.1352)

4-methylumbelliferyl-beta-d-lactoside

C22H28O13 (500.153)

TMRM Perchlorate

C25H25ClN2O7 (500.135)

Demeclocycline hydrochloride

C21H22Cl2N2O8 (500.0753)

C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Demeclocycline hydrochloride is a tetracycline antibiotic; is an antibiotic in the treatment of Lyme disease, acne, and bronchitis.

Sibenadet hydrochloride

C22H29ClN2O5S2 (500.1206)

ICI 204,448 hydrochloride

C23H27Cl3N2O4 (500.1036)

ICI-204448 is a κ-opioid agonist with limited access to the CNS, ICI-204448 can displace the binding of the kappa-opioid ligand 3H-bremazocine from guinea pig cerebellum membranes[1].

[4,5,8-triacetyloxy-6-(1-acetyloxy-4-methylpent-3-enyl)naphthalen-1-yl] acetate

C26H28O10 (500.1682)

2,2,2-Triphenyl-1,3,2λ5-dioxabismetan-4-one

C19H15BiO3 (500.0825)

Pitavastatin calcium

C25H23FNO4.1/2 Ca (500.0863)

Pitavastatin Calcium (NK-104 hemicalcium) is a potent hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor. Pitavastatin Calcium (NK-104 hemicalcium) inhibits cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in HepG2 cells. Pitavastatin Calcium is an efficient hepatocyte low-density lipoprotein-cholesterol (LDL-C) receptor inducer. Pitavastatin Calcium also possesses anti-atherosclerotic, anti-asthmatic, anti-osteoarthritis, antineoplastic, neuroprotective, hepatoprotective and reno-protective effects[1][2][3][8].

METHYL 2-(4-((3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHYNYL)-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-YL)-3-METHOXYACRYLATE

C20H13F9N2O3 (500.0782)

Teclozan

C20H28Cl4N2O4 (500.0803)

P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases > P01AC - Dichloroacetamide derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

4-hexyl-2-(4-hexyl-5-thiophen-2-yl-1,3-thiazol-2-yl)-5-thiophen-2-yl-1,3-thiazole

C26H32N2S4 (500.1448)

Regorafenib Monohydrate

C21H17ClF4N4O4 (500.0874)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Regorafenib (BAY 73-4506) monohydrate is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib monohydrate shows very robust antitumor and antiangiogenic activity[1].

4-Methylumbelliferyl beta-D-cellobioside

C22H28O13 (500.153)

9,9-spirobi[fluoren]-2-yldiphenylphosphane

C37H25P (500.1694)

6-Hydroxy Warfarin β-D-Glucuronide

C25H24O11 (500.1319)

Uredofos

C19H25N4O6PS2 (500.0953)

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

8-BroMo-5-O-(4-cyanobenzyl)-2,3-O-isopropylidene adenosine

C21H21BrN6O4 (500.0808)

5-(4-CHLOROPHENYL)-1-(2,4-DICHLOROPHENYL)-4-METHYLPYRAZOLE-3-CARBOXYLICACID

C27H34BrO2P (500.148)

(6R,7R)-3-Hydroxy-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenyl methyl ester

C28H24N2O5S (500.1406)

Benzoic acid, 4-(((2,3-dihydro-6-((2-methylpropyl)(2-thiazolylsulfonyl)amino)-1H-inden-5-yl)oxy)methyl)-3-methyl-

C25H28N2O5S2 (500.144)

Simotinib

C25H26ClFN4O4 (500.1627)

Eotube

C20H28N4O9S (500.1577)

Haploperoside

C22H28O13 (500.153)

A natural product found in Citropsis articulata.

Quaterrylene

C40H20 (500.1565)

5-hydroxy-2-methylchromone-7-O-rutinoside

C22H28O13 (500.153)

A disaccharide derivative that consists of 5-hydroxy-2-methylchromone substituted by a rutinosyl group at position 7 via a glycosidic linkage. Isolated from Crossosoma bigelovii, it exhibits antineoplastic activity.

1843U89;(2S)-2-(5-{[(3-Methyl-1-oxo-1,2-dihydrobenzo[f]quinazolin-9-yl)me thyl]amino}-1-oxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioic acid

C27H24N4O6 (500.1696)

S)-2-(5(((1,2-Dihydro-3-methyl-1-oxobenzo(F)quinazolin-9-YL)methyl)amino)1-oxo-2-isoindolinyl)glutaric acid

C27H24N4O6 (500.1696)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000970 - Antineoplastic Agents

(+)-Neocarzinostatin chromophore aglycone

C28H20O9 (500.1107)

2-glutathion-S-yl-3-(4-nitrophenyl) propionic acid

C19H24N4O10S (500.1213)

(2S)-2-amino-4-[4-[(E)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-hydroxycarbonimidoyl]phenoxy]butanoic acid

C23H24N4O9 (500.1543)

GS-Hpv II

C20H26N3O10S- (500.1339)

GS-Hpv I

C20H26N3O10S- (500.1339)

(3S,alphaR)-3-[[[4-[(R)-3-Amino-3-carboxypropoxy]phenyl]-[(Z)-hydroxyimino]acetyl]amino]-alpha-(4-hydroxyphenyl)-2-oxo-1-azetidineacetic acid

C23H24N4O9 (500.1543)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

7-(4-hydroxyphenyl)-11-oxo-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid

C24H20O12 (500.0955)

2-amino-6-O-(2-amino-2-deoxy-4-O-phosphono-beta-D-glucopyranosyl)-2-deoxy-1-O-phosphono-alpha-D-glucopyranose

C12H26N2O15P2 (500.0808)

[4-[(2-Chlorophenyl)methylsulfonyl]-3-nitrophenyl]-[4-(2-pyridinyl)-1-piperazinyl]methanone

C23H21ClN4O5S (500.0921)

2-[cyclopentyl-[1-oxo-2-(5-thiophen-2-yl-2-tetrazolyl)ethyl]amino]-N-(2-oxolanylmethyl)-2-thiophen-2-ylacetamide

C23H28N6O3S2 (500.1664)

2-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxo-1-imidazolidinyl]-N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide

C27H24N4O4S (500.1518)

2-(4-morpholinyl)-9-(3-thiophenyl)-N-[[6-(trifluoromethyl)-1H-benzimidazol-2-yl]methyl]-6-purinamine

C22H19F3N8OS (500.1355)

2-[(1R,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

N-[(2R,3R)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

2-[(1S,3S,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

N-[(2R,3S)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[[(4R,5R)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4R,5R)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4S,5R)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4R,5S)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

2-[(1R,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

N-[(2S,3R)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[(2R,3S)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[[(4S,5S)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4S,5S)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4S,5R)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

N-[[(4R,5S)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide

C22H29FN2O6S2 (500.1451)

2-[(1S,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide

C22H23F3N2O6S (500.1229)

N-[(2S,3S)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[(2S,3R)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[(2S,3S)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

(beta-D-glucopyranosyloxymethyl)deoxyuridine 5-monophosphate

C16H25N2O14P (500.1043)

A pyrimidine 2-deoxyribonucleoside 5-monophosphate having beta-D-glucopyranosyloxymethyluracil (base J) as the nucleobase

Glu-Phe-Cys-Cys

C20H28N4O7S2 (500.1399)

(2S)-2-ammonio-4-{4-[(1Z)-2-({(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}amino)-N-hydroxy-2-oxoethanimidoyl]phenoxy}butanoate

C23H24N4O9 (500.1543)

6-({5-[3-(2H-1,3-benzodioxol-5-yl)-3-oxopropanoyl]-1-benzofuran-4-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C24H20O12 (500.0955)

7-(4-hydroxyphenyl)-11-oxo-6-[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid

C24H20O12 (500.0955)

6-Hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

C24H20O12 (500.0955)

Isonocardicin A

C23H24N4O9 (500.1543)

A nocardicin in which the beta-lactam moiety is substituted at position 1 by a carboxy(4-hydroxyphenyl)methyl group and at position 3 by a [(2Z)-2-(hydroxyimino)-2-(4-hydroxyphenyl)acetyl]nitrilo group in which the phenolic hydroxy group is substituted by a (3S)-3-amino-3-carboxypropyl group.

Lyoniresinol 9-sulfate

C22H28O11S (500.1352)

beta-GlcN-4P-(1->6)-alpha-D-GlcN-1P

C12H26N2O15P2 (500.0808)

A 1,4-bisphosphorylated glucosamine disaccharide corresponding to the carbohydrate portion of E. coli J-5 lipid A.

isonocardicin A zwitterion

C23H24N4O9 (500.1543)

An L-alpha-amino acid zwitterion resulting from the transfer of a proton from the carboxy group to the amino group of isonocardicin A.

ST 22:5;O8;S

C22H28O11S (500.1352)

ST 23:4;O7;S

C23H32O10S (500.1716)

4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol

C29H24O8 (500.1471)

2-(3,5-diformyl-2,4,6-trihydroxyphenyl)-5,7-dihydroxy-3-isopropyl-4-(2-methylpropyl)-3,4-dihydro-2h-1-benzopyran-6,8-dicarbaldehyde

C26H28O10 (500.1682)

methyl (3r)-4-{6-[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]-1,5-dihydroxy-9,10-dioxoanthracen-2-yl}-3-hydroxy-3-methylbutanoate

C26H28O10 (500.1682)

(11s,12r)-6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-triene-8,11-diol

C29H24O8 (500.1471)

(8r,10s)-10-{[(2r,3r,4r,5r,6s)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl]oxy}-1,8,11-trihydroxy-8-methyl-9,10-dihydro-7h-tetracene-5,12-dione

C26H28O10 (500.1682)

4,7-dimethoxy-3-methyl-5-[(1e)-2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethenyl]chromen-2-one

C26H28O10 (500.1682)

5-[(2s,3s)-7-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]-6-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1-benzofuran-3-yl]benzene-1,3-diol

C29H24O8 (500.1471)

(1e,2r,3r)-3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

(2r,3s)-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C21H24O12S (500.0988)

(2s,3r,4s,5s,6r)-2-[(3-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

5-[(2r,3s)-8-formyl-5,7-dihydroxy-3-isopropyl-6-(3-methylbutanoyl)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde

C26H28O10 (500.1682)

4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,3-diol

C29H24O8 (500.1471)

7-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)-3-methyloxolan-2-yl]oxy}methyl)-3,4,5-trihydroxy-3-methyloxan-2-yl]oxy}-6-hydroxychromen-2-one

C22H28O13 (500.153)

(8s,9s)-16-(3,4-dihydroxyphenyl)-8-(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaene-3,4,6,9,12-pentol

C28H20O9 (500.1107)

7-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-6-methoxychromen-2-one

C22H28O13 (500.153)

3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one

C26H28O10 (500.1682)

6,7-dihydroxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 4-hydroxybenzoate

C22H28O13 (500.153)

5-(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-4-hydroxy-6-methyloxan-3-yl acetate

C25H24O11 (500.1319)

(4s,5s,11s,12r)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

12alpha-Hydroxyevodol

C26H28O10 (500.1682)

{"Ingredient_id": "HBIN000707","Ingredient_name": "12alpha-Hydroxyevodol","Alias": "12alpha-hydroxyevodol; 12\u03b1-hydroxyevodol","Ingredient_formula": "C26H28O10","Ingredient_Smile": "CC1(C2=C(C(=O)C3(C(C24COC(=O)CC4O1)CC(C5(C36C(O6)C(=O)OC5C7=COC=C7)C)O)C)O)C","Ingredient_weight": "500.5 g/mol","OB_score": "19.40751811","CAS_id": "NA","SymMap_id": "SMIT01183;SMIT15841","TCMID_id": "31192;10117","TCMSP_id": "MOL003976","TCM_ID_id": "19312","PubChem_id": "129317030","DrugBank_id": "NA"}

5-methylcoumarin-4-cellobioside

C22H28O13 (500.153)

{"Ingredient_id": "HBIN011802","Ingredient_name": "5-methylcoumarin-4-cellobioside","Alias": "NA","Ingredient_formula": "C22H28O13","Ingredient_Smile": "CC1=C2C(=CC=C1)OC(=O)C=C2OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)CO)O)O)O)O)O","Ingredient_weight": "500.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14248","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "196631","DrugBank_id": "NA"}

5-methylcoumarin-4-gentiobioside

C22H28O13 (500.153)

{"Ingredient_id": "HBIN011803","Ingredient_name": "5-methylcoumarin-4-gentiobioside","Alias": "NA","Ingredient_formula": "C22H28O13","Ingredient_Smile": "CC1=C2C(=CC=C1)OC(=O)C=C2OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O","Ingredient_weight": "500.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14249","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "3080987","DrugBank_id": "NA"}

methyl (3s)-3-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3-(2,4,5-trihydroxyphenyl)propanoate

C25H24O11 (500.1319)

(1z,2s,3s)-3-(3,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

(2r,3r,4r)-4-{2-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4,6-dihydroxyphenyl}-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol

C29H24O8 (500.1471)

(2r)-2-amino-4-{4-[(e)-{[(3s)-1-[(r)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

5-[8-formyl-5,7-dihydroxy-3-isopropyl-6-(3-methylbutanoyl)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde

C26H28O10 (500.1682)

(2s,3s,4s,5r,6s)-3-(acetyloxy)-6-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-hydroxy-2-methyloxan-4-yl acetate

C25H24O11 (500.1319)

(2r,3r,4s)-2-(3,5-diformyl-2,4,6-trihydroxyphenyl)-5,7-dihydroxy-3-isopropyl-4-(2-methylpropyl)-3,4-dihydro-2h-1-benzopyran-6,8-dicarbaldehyde

C26H28O10 (500.1682)

(2s,3r,4s,5s,6r)-2-[(4-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one

C26H28O10 (500.1682)

4-[3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,3-diol

C29H24O8 (500.1471)

2,6-dihydroxy-4-{[(2s,3r,4s,5r,6r)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}benzoic acid

C21H24O14 (500.1166)

(2s)-2-amino-4-{4-[(z)-{[(3s)-1-[(s)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

(2s,3r,4r,5s,6s)-3-(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-hydroxy-6-methyloxan-4-yl acetate

C25H24O11 (500.1319)

(2s,3r,4s,5s,6r)-2-[(5-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

(2r,3s,4s)-2-(3,5-diformyl-2,4,6-trihydroxyphenyl)-5,7-dihydroxy-3-isopropyl-4-(2-methylpropyl)-3,4-dihydro-2h-1-benzopyran-6,8-dicarbaldehyde

C26H28O10 (500.1682)

7-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-methoxychromen-2-one

C22H28O13 (500.153)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[4'-methoxy-4-(4-methoxyphenyl)-[1,1'-biphenyl]-2,6-diyl]oxy}oxane-3,4,5-triol

C26H28O10 (500.1682)

2-(3,4-dihydroxyphenyl)ethyl 1-hydroxy-9-[2-(4-hydroxyphenyl)ethoxy]-6-oxo-1h,4ah,5h,8h,9h,9ah-pyrano[3,4-d]oxepine-4-carboxylate

C26H28O10 (500.1682)

6-(acetyloxy)-2,4',5-trihydroxy-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-3-yl 3-phenylpropanoate

C29H24O8 (500.1471)

16-(3,4-dihydroxyphenyl)-8-(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaene-3,4,6,9,12-pentol

C28H20O9 (500.1107)

4-{2-[2-(3,4-dihydroxyphenyl)ethenyl]-4,6-dihydroxyphenyl}-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol

C29H24O8 (500.1471)

2,4-dihydroxy-7-(4-hydroxy-2-methoxy-6-methylphenyl)-9-methoxy-12,12-dimethyltetracene-5,6,11-trione

C29H24O8 (500.1471)

methyl 3-[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3-(2,4,5-trihydroxyphenyl)propanoate

C25H24O11 (500.1319)

(1r,4s,5r,6s,7r,8s,9s)-4,5-dihydroxy-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,10-dioxatricyclo[5.3.1.0⁴,⁸]undecan-6-yl 4-hydroxybenzoate

C22H28O13 (500.153)

(7s,9r)-6,9-dihydroxy-2-methoxy-9-methyl-7-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-8,10-dihydro-7h-tetracene-5,12-dione

C26H28O10 (500.1682)

(2r,3s)-3,7-bis(acetyloxy)-2-[3,4-bis(acetyloxy)phenyl]-3,4-dihydro-2h-1-benzopyran-5-yl acetate

C25H24O11 (500.1319)

4,5-dihydroxy-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,10-dioxatricyclo[5.3.1.0⁴,⁸]undecan-6-yl 4-hydroxybenzoate

C22H28O13 (500.153)

methyl (3r)-3-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-6-yl]-3-(2,4,5-trihydroxyphenyl)propanoate

C25H24O11 (500.1319)

5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one

C26H28O10 (500.1682)

3-(acetyloxy)-6-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-hydroxy-2-methyloxan-4-yl acetate

C25H24O11 (500.1319)

4,7-dimethoxy-3-methyl-5-[2-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethenyl]chromen-2-one

C26H28O10 (500.1682)

6,9-dihydroxy-2-methoxy-9-methyl-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-8,10-dihydro-7h-tetracene-5,12-dione

C26H28O10 (500.1682)

(1e,2s,3s)-3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

4-[3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol

C29H24O8 (500.1471)

5-[11-(2,4-dihydroxyphenyl)-12-(3,5-dihydroxyphenyl)-8-hydroxy-5,10-dioxatricyclo[7.3.0.0²,⁶]dodeca-1,3,6,8-tetraen-4-yl]benzene-1,3-diol

C28H20O9 (500.1107)

(11r,12s)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

6-methoxy-7-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]chromen-2-one

C22H28O13 (500.153)

2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-n-[2-(methoxycarbonyl)phenyl]-4-(methylsulfanyl)butanimidic acid

C22H24N6O6S (500.1478)

(4s,5s,11r,12s)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxan-2-yl]methyl (2e)-but-2-enoate

C25H24O11 (500.1319)

6-methoxy-7-{[(2s,3r,4s,5s)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}chromen-2-one

C22H28O13 (500.153)

6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-triene-8,11-diol

C29H24O8 (500.1471)

(3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxan-2-yl)methyl but-2-enoate

C25H24O11 (500.1319)

(2r,3r)-7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-5-methoxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C25H24O11 (500.1319)

(2s)-2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-n-[2-(methoxycarbonyl)phenyl]-4-(methylsulfanyl)butanimidic acid

C22H24N6O6S (500.1478)

(2r,3r,4r)-2-(3,5-diformyl-2,4,6-trihydroxyphenyl)-5,7-dihydroxy-3-isopropyl-4-(2-methylpropyl)-3,4-dihydro-2h-1-benzopyran-6,8-dicarbaldehyde

C26H28O10 (500.1682)

(5r,6r,11s,12r)-6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-triene-8,11-diol

C29H24O8 (500.1471)

(2r,3r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one

C29H24O8 (500.1471)

5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

(1r,3r,4s,5r)-3-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,5-dihydroxy-4-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}cyclohexane-1-carboxylic acid

C25H24O11 (500.1319)

3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one

C29H24O8 (500.1471)

(8s,9r)-16-(3,4-dihydroxyphenyl)-8-(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaene-3,4,6,9,12-pentol

C28H20O9 (500.1107)

(1s,4ar,5s,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 4-hydroxybenzoate

C22H28O13 (500.153)

(2r)-2-amino-4-{4-[(z)-{[(3s)-1-[(r)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

5-{7-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]-6-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1-benzofuran-3-yl}benzene-1,3-diol

C29H24O8 (500.1471)

2-amino-4-{4-[(z)-({1-[carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}-c-hydroxycarbonimidoyl)(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

2-amino-4-{4-[({1-[carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}-c-hydroxycarbonimidoyl)(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

2-(3,4-dihydroxyphenyl)ethyl (1r,4as,9s,9as)-1-hydroxy-9-[2-(4-hydroxyphenyl)ethoxy]-6-oxo-1h,4ah,5h,8h,9h,9ah-pyrano[3,4-d]oxepine-4-carboxylate

C26H28O10 (500.1682)

2-[(4-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

7-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)-3-methyloxolan-2-yl]oxy}methyl)-3,4,5-trihydroxy-3-methyloxan-2-yl]oxy}-6-hydroxychromen-2-one

C22H28O13 (500.153)

2-(hydroxymethyl)-6-{[4'-methoxy-4-(4-methoxyphenyl)-[1,1'-biphenyl]-2,6-diyl]oxy}oxane-3,4,5-triol

C26H28O10 (500.1682)

(2s,3r,4r,5r,6s)-5-(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-4-hydroxy-6-methyloxan-3-yl acetate

C25H24O11 (500.1319)

(1r,2s,3e)-1-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-3-[(4-hydroxy-3-methoxyphenyl)methylidene]-1,2-dihydroindene-5,6-diol

C29H24O8 (500.1471)

(2r,3r)-3,7-bis(acetyloxy)-2-[3,4-bis(acetyloxy)phenyl]-3,4-dihydro-2h-1-benzopyran-5-yl acetate

C25H24O11 (500.1319)

(8r,9s)-16-(3,4-dihydroxyphenyl)-8-(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaene-3,4,6,9,12-pentol

C28H20O9 (500.1107)

3-(acetyloxy)-2-[(4,5-dihydroxy-7-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-hydroxy-6-methyloxan-4-yl acetate

C25H24O11 (500.1319)

2-(2,4-dichloro-5-methoxy-3-methylphenoxy)-6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxane-3,4,5-triol

C19H26Cl2O11 (500.0852)

2-[(5-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

2,6-dihydroxy-4-{[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}benzoic acid

C21H24O14 (500.1166)

5-hydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-en-1-yl)-7-{[(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one

C26H28O10 (500.1682)

5-hydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-en-1-yl)-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one

C26H28O10 (500.1682)

5-hydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-en-1-yl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one

C26H28O10 (500.1682)

7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-5-methoxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C25H24O11 (500.1319)

3,7-bis(acetyloxy)-2-[3,4-bis(acetyloxy)phenyl]-3,4-dihydro-2h-1-benzopyran-5-yl acetate

C25H24O11 (500.1319)